Back to results
US 2010/0063147 A1Published application
Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases
AssigneeInserm (Institut National De La Sante Et De La Recherche Medicale)
InventorsAlexandra Durr, Fanny Mochel
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for treating and/or preventing Huntington disease and other polyglutamine diseases, comprising the step of administering an effective amount of a precursor of propionyl-CoA to an individual in need thereof.
Claims16
A method of treating and/or preventing a polyglutamine disease comprising administering a precursor of propionyl-CoA in an amount effective for treating and/or preventing a polyglutamine disease.
Dependencies are inferred from the claim text.